Decibel Cannabis Co Inc (DBCCF)
0.0512
0.00 (0.00%)
USD |
OTCM |
Jun 21, 16:00
Decibel Cannabis Profit Margin (Quarterly): 1.37% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.37% |
| June 30, 2023 | -1.37% |
| March 31, 2023 | -2.10% |
| December 31, 2022 | -12.20% |
| September 30, 2022 | 28.21% |
| June 30, 2022 | -11.38% |
| March 31, 2022 | -26.26% |
| December 31, 2021 | 4.67% |
| September 30, 2021 | -6.83% |
| June 30, 2021 | -4.98% |
| Date | Value |
|---|---|
| March 31, 2021 | 20.77% |
| December 31, 2020 | -14.76% |
| September 30, 2020 | -17.97% |
| June 30, 2020 | -47.51% |
| March 31, 2020 | -66.78% |
| December 31, 2019 | -390.2% |
| September 30, 2019 | -13.51% |
| June 30, 2019 | 79.41% |
| March 31, 2019 | -12.01K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-390.2%
Minimum
Dec 2019
79.41%
Maximum
Jun 2019
-26.75%
Average
-9.11%
Median
Profit Margin (Quarterly) Benchmarks
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | -59.60% |
| Edesa Biotech Inc | -- |
| Lexaria Bioscience Corp | -448.0% |
| Xenon Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -7.79% |
| Return on Assets | -2.62% |
| Return on Invested Capital | -4.09% |
| Gross Profit Margin (Quarterly) | 42.16% |
| Operating Margin (Quarterly) | 12.27% |
| Return on Net Operating Assets | -2.69% |